- Home
- CSGS vs LGND Comparison
CSGS vs LGND Comparison
Compare CSGS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGS
- LGND
- Stock Information
- Founded
- CSGS 1994
- LGND 1987
- Country
- CSGS United States
- LGND United States
- Employees
- CSGS N/A
- LGND N/A
- Industry
- CSGS EDP Services
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- CSGS Technology
- LGND Health Care
- Exchange
- CSGS Nasdaq
- LGND Nasdaq
- Market Cap
- CSGS 1.8B
- LGND 2.0B
- IPO Year
- CSGS 1996
- LGND 1992
- Fundamental
- Price
- CSGS $66.06
- LGND $102.19
- Analyst Decision
- CSGS Buy
- LGND Strong Buy
- Analyst Count
- CSGS 7
- LGND 8
- Target Price
- CSGS $68.29
- LGND $144.71
- AVG Volume (30 Days)
- CSGS 291.6K
- LGND 118.3K
- Earning Date
- CSGS 05-07-2025
- LGND 05-08-2025
- Dividend Yield
- CSGS 1.94%
- LGND N/A
- EPS Growth
- CSGS 33.32
- LGND N/A
- EPS
- CSGS 2.92
- LGND N/A
- Revenue
- CSGS $1,201,566,000.00
- LGND $181,488,000.00
- Revenue This Year
- CSGS $3.15
- LGND $17.68
- Revenue Next Year
- CSGS $3.72
- LGND $18.69
- P/E Ratio
- CSGS $22.60
- LGND N/A
- Revenue Growth
- CSGS 3.08
- LGND 53.40
- 52 Week Low
- CSGS $39.56
- LGND $77.43
- 52 Week High
- CSGS $67.60
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- CSGS 62.96
- LGND 44.63
- Support Level
- CSGS $65.14
- LGND $98.90
- Resistance Level
- CSGS $66.65
- LGND $103.17
- Average True Range (ATR)
- CSGS 1.17
- LGND 3.05
- MACD
- CSGS 0.03
- LGND -0.27
- Stochastic Oscillator
- CSGS 82.38
- LGND 31.94
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.